MedTrace Logo

Prospective Clinical Trial of the LensAR Laser System

NCT01014702 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2011-04-15

No results posted yet for this study

Summary

The LensAR Laser System is used to create an opening in the anterior capsule of the lens and fragments the cataractous lens. The study will evaluate clinical outcomes compared to the contra-lateral eye treated with conventional phacoemulsification surgery.

Conditions

  • Cataract

Interventions

DEVICE

LensAR Laser System

Use of laser for capsulotomy and lens fragmentation

DEVICE

Conventional phacoemulsification

Use of standard techniques for capsulotomy and lens fragmentation

Sponsors & Collaborators

  • LensAR Incorporated

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2011-06-30
Completion
2011-06-30

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01014702 on ClinicalTrials.gov